U.S. Pharmaceutical Sales - Q1 2013
The following is a list of the top 100 prescribed medicines by US National Sales in Q1 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2013 by units sold
Rank |
Drug |
Units (000) |
|
|
1 |
budesonide Generic |
12,470 |
0.81% |
Stats |
2 |
acetaminophen/hydrocodone Generic |
10,024 |
-2.92% |
Stats |
3 ( ) |
omeprazole Generic |
8,048 |
n/a |
Stats |
4 ( 1) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
6,765 |
-11.64% |
Stats |
5 ( 1) |
Nexium AstraZeneca |
6,667 |
-2.47% |
Stats |
6 ( 1) |
Cymbalta
|
6,502 |
-2.09% |
Stats |
7 ( 1) |
atorvastatin Generic |
6,388 |
4.70% |
Stats |
8 ( 1) |
OneTouch
|
6,110 |
-0.70% |
Stats |
9 |
Ventolin HFA GlaxoSmithKline |
6,063 |
1.27% |
Stats |
10 |
Advair Diskus GlaxoSmithKline |
5,959 |
1.81% |
Stats |
11 ( 5) |
Lantus Sanofi |
5,790 |
-9.19% |
Stats |
12 ( 1) |
Lantus Solostar Sanofi |
4,928 |
5.57% |
Stats |
13 |
enoxaparin Generic |
4,311 |
-0.90% |
Stats |
14 ( 9) |
Tamiflu
|
4,205 |
67.13% |
Stats |
15 ( 1) |
Crestor AstraZeneca |
4,106 |
-2.93% |
Stats |
16 ( 4) |
fentanyl Generic |
4,078 |
-6.62% |
Stats |
17 ( 2) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,609 |
-1.50% |
Stats |
18 ( 1) |
Levemir Novo Nordisk |
3,348 |
4.92% |
Stats |
19 ( 3) |
Novolog Novo Nordisk |
3,040 |
-10.03% |
Stats |
20 ( 2) |
NovoLog FlexPen Novo Nordisk |
2,979 |
-1.52% |
Stats |
21 ( 4) |
metoprolol Generic |
2,854 |
16.39% |
Stats |
22 ( 2) |
Humalog Eli Lilly and Company |
2,708 |
2.85% |
Stats |
23 ( 1) |
Nasonex Merck |
2,655 |
4.32% |
Stats |
24 |
Synthroid AbbVie Inc. |
2,484 |
1.22% |
Stats |
25 ( 4) |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,477 |
-5.89% |
Stats |
26 |
Januvia Merck |
2,378 |
0.38% |
Stats |
27 |
Symbicort AstraZeneca |
2,210 |
-4.45% |
Stats |
28 ( 1) |
Lyrica
|
2,074 |
0.29% |
Stats |
29 ( 1) |
Suboxone
|
2,066 |
0.58% |
Stats |
30 ( 2) |
Namenda Allergan plc |
2,011 |
-3.55% |
Stats |
31 |
Zetia Merck |
1,995 |
0.86% |
Stats |
32 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
1,923 |
1.75% |
Stats |
33 ( 1) |
Flovent HFA GlaxoSmithKline |
1,907 |
-2.80% |
Stats |
34 |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
1,765 |
-1.89% |
Stats |
35 ( 16) |
AndroGel AbbVie Inc. |
1,687 |
-40.11% |
Stats |
36 ( 1) |
Lidoderm Endo Pharmaceuticals Inc. |
1,650 |
-5.23% |
Stats |
37 ( 5) |
fenofibrate Generic |
1,618 |
26.11% |
Stats |
38 ( 1) |
Remicade Janssen Pharmaceuticals, Inc. |
1,590 |
2.51% |
Stats |
39 ( 3) |
Lovaza GlaxoSmithKline |
1,570 |
-4.33% |
Stats |
40 ( 1) |
Benicar Daiichi Sankyo |
1,499 |
-0.27% |
Stats |
41 ( 1) |
Dexilant Takeda Pharmaceutical Company Limited |
1,495 |
0.13% |
Stats |
42 ( 4) |
Restasis Allergan plc |
1,490 |
-3.62% |
Stats |
43 |
OxyContin Purdue Pharma LP |
1,176 |
-5.47% |
Stats |
44 ( ) |
Benicar HCT Daiichi Sankyo |
1,155 |
n/a |
Stats |
45 ( ) |
Humalog KwikPen Eli Lilly and Company |
1,137 |
n/a |
Stats |
46 ( 1) |
VESIcare Astellas Pharma US, Inc. |
1,126 |
6.03% |
Stats |
47 ( 3) |
Vytorin Merck |
1,069 |
-4.30% |
Stats |
48 ( 2) |
Celebrex
|
1,009 |
-4.90% |
Stats |
49 ( 1) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
983 |
-0.20% |
Stats |
50 ( 1) |
Janumet Merck |
971 |
-0.61% |
Stats |
51 ( 4) |
Enbrel Amgen Inc. |
969 |
-6.83% |
Stats |
52 ( 2) |
Niaspan AbbVie Inc. |
902 |
-4.25% |
Stats |
53 ( 2) |
Evista
|
878 |
-4.25% |
Stats |
54 ( ) |
doxycycline Generic |
849 |
n/a |
Stats |
55 ( ) |
hydrochlorothiazide/valsartan Generic |
839 |
n/a |
Stats |
56 ( 1) |
Cialis Eli Lilly and Company |
836 |
2.20% |
Stats |
57 ( 5) |
methylphenidate Generic |
826 |
-1.90% |
Stats |
58 ( 4) |
Vyvanse Takeda Pharmaceutical Company Limited |
814 |
-2.75% |
Stats |
59 ( 3) |
amphetamine/dextroamphetamine Generic |
764 |
-0.13% |
Stats |
60 ( 3) |
Aciphex Eisai Inc. |
652 |
-10.56% |
Stats |
61 ( 3) |
Humira AbbVie Inc. |
631 |
-5.68% |
Stats |
62 |
Victoza Novo Nordisk |
607 |
9.76% |
Stats |
63 ( 3) |
Epogen Amgen Inc. |
590 |
-2.64% |
Stats |
64 ( 5) |
Rebif EMD Serono, Inc. |
562 |
-8.17% |
Stats |
65 ( 2) |
Rituxan Genentech, Inc. |
560 |
1.82% |
Stats |
66 ( 5) |
Truvada Gilead Sciences, Inc. |
548 |
-8.51% |
Stats |
67 ( 1) |
Atripla Gilead Sciences, Inc. |
479 |
-0.83% |
Stats |
68 ( 1) |
Avastin Genentech, Inc. |
462 |
n/a |
Stats |
69 ( 5) |
Viagra
|
442 |
-12.48% |
Stats |
70 ( 2) |
Seroquel XR AstraZeneca |
406 |
-4.69% |
Stats |
71 ( 2) |
modafinil Generic |
371 |
-6.78% |
Stats |
72 ( 2) |
Renvela Sanofi |
354 |
-1.39% |
Stats |
73 ( 2) |
Lunesta Sunovion Pharmaceuticals Inc. |
336 |
-2.61% |
Stats |
74 ( 1) |
Neulasta Amgen Inc. |
329 |
4.11% |
Stats |
75 ( 3) |
Adderall XR Takeda Pharmaceutical Company Limited |
326 |
-3.26% |
Stats |
76 ( 3) |
Orencia Bristol-Myers Squibb Company |
325 |
-0.91% |
Stats |
77 ( 3) |
Sensipar Amgen Inc. |
309 |
-4.92% |
Stats |
78 ( 2) |
Focalin XR Novartis Pharmaceuticals Corporation |
291 |
-5.21% |
Stats |
79 ( 1) |
Xolair
|
276 |
-0.72% |
Stats |
80 ( 3) |
Procrit Janssen Pharmaceuticals, Inc. |
270 |
-3.23% |
Stats |
81 ( 1) |
Isentress Merck |
269 |
-0.37% |
Stats |
82 ( 3) |
Reyataz Bristol-Myers Squibb Company |
262 |
-5.42% |
Stats |
83 ( 2) |
Aranesp Amgen Inc. |
247 |
-4.63% |
Stats |
84 ( 1) |
Prezista Janssen Pharmaceuticals, Inc. |
245 |
-0.41% |
Stats |
85 ( 1) |
Lucentis Genentech, Inc. |
242 |
6.14% |
Stats |
86 ( 3) |
Synagis MedImmune, Inc. |
238 |
44.24% |
Stats |
87 ( 5) |
Copaxone Teva Pharmaceuticals USA, Inc. |
229 |
-8.03% |
Stats |
88 ( 2) |
Alimta Eli Lilly and Company |
179 |
-9.60% |
Stats |
89 ( 1) |
Herceptin Genentech, Inc. |
167 |
1.83% |
Stats |
90 ( 2) |
Neupogen Amgen Inc. |
163 |
-4.12% |
Stats |
91 ( 4) |
Prevnar 13 Pfizer Inc. |
154 |
-13.97% |
Stats |
92 ( 1) |
Zyvox Pfizer Inc. |
142 |
11.81% |
Stats |
93 ( 1) |
Xgeva Amgen Inc. |
122 |
5.17% |
Stats |
94 ( 1) |
Avonex Biogen |
97 |
-13.39% |
Stats |
95 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
82 |
-5.75% |
Stats |
96 ( 1) |
Xeloda Genentech, Inc. |
59 |
-9.23% |
Stats |
97 |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
57 |
-6.56% |
Stats |
98 |
Gilenya Novartis Pharmaceuticals Corporation |
56 |
-1.75% |
Stats |
99 |
Stelara Janssen Pharmaceuticals, Inc. |
24 |
4.35% |
Stats |
100 |
Incivek Vertex Pharmaceuticals Incorporated |
14 |
-12.50% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.